122 related articles for article (PubMed ID: 9027594)
21. Expression of cyclins and cdks throughout murine carcinogenesis.
Yerly-Motta V; Contassot E; Pavy JJ; Tiberghien P; Hervé P
Cell Mol Biol (Noisy-le-grand); 1999 Dec; 45(8):1217-28. PubMed ID: 10643971
[TBL] [Abstract][Full Text] [Related]
22. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E
Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653
[TBL] [Abstract][Full Text] [Related]
23. Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells.
Davis T; Kennedy C; Chiew YE; Clarke CL; deFazio A
Clin Cancer Res; 2000 Nov; 6(11):4334-42. PubMed ID: 11106251
[TBL] [Abstract][Full Text] [Related]
24. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
[TBL] [Abstract][Full Text] [Related]
25. Cyclin D1 in breast cancer pathogenesis.
Arnold A; Papanikolaou A
J Clin Oncol; 2005 Jun; 23(18):4215-24. PubMed ID: 15961768
[TBL] [Abstract][Full Text] [Related]
26. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification.
Izzo JG; Papadimitrakopoulou VA; Li XQ; Ibarguen H; Lee JS; Ro JY; El-Naggar A; Hong WK; Hittelman WN
Oncogene; 1998 Nov; 17(18):2313-22. PubMed ID: 9811462
[TBL] [Abstract][Full Text] [Related]
27. ErbB-2 induces the cyclin D1 gene in prostate epithelial cells in vitro and in vivo.
Casimiro M; Rodriguez O; Pootrakul L; Aventian M; Lushina N; Cromelin C; Ferzli G; Johnson K; Fricke S; Diba F; Kallakury B; Ohanyerenwa C; Chen M; Ostrowski M; Hung MC; Rabbani SA; Datar R; Cote R; Pestell R; Albanese C
Cancer Res; 2007 May; 67(9):4364-72. PubMed ID: 17483350
[TBL] [Abstract][Full Text] [Related]
28. Expression of cyclins D1 and E in human colon adenocarcinomas.
Sutter T; Doi S; Carnevale KA; Arber N; Weinstein IB
J Med; 1997; 28(5-6):285-309. PubMed ID: 9604788
[TBL] [Abstract][Full Text] [Related]
29. The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1.
Burnworth B; Arendt S; Muffler S; Steinkraus V; Bröcker EB; Birek C; Hartschuh W; Jauch A; Boukamp P
Eur J Cell Biol; 2007 Dec; 86(11-12):763-80. PubMed ID: 17198740
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer.
Bali A; O'Brien PM; Edwards LS; Sutherland RL; Hacker NF; Henshall SM
Clin Cancer Res; 2004 Aug; 10(15):5168-77. PubMed ID: 15297421
[TBL] [Abstract][Full Text] [Related]
31. Molecular chemoprevention by selenium: a genomic approach.
El-Bayoumy K; Sinha R
Mutat Res; 2005 Dec; 591(1-2):224-36. PubMed ID: 16099479
[TBL] [Abstract][Full Text] [Related]
32. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of cyclin D1 and cyclin E in 1,2-dimethylhydrazine dihydrochloride-induced rat colon carcinogenesis.
Hur K; Kim JR; Yoon BI; Lee JK; Choi JH; Oh GT; Kim DY
J Vet Sci; 2000 Dec; 1(2):121-6. PubMed ID: 14614307
[TBL] [Abstract][Full Text] [Related]
34. The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment--twenty-seventh G.H.A. Clowes memorial award lecture.
Weinstein IB
Cancer Res; 1988 Aug; 48(15):4135-43. PubMed ID: 3292040
[TBL] [Abstract][Full Text] [Related]
35. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
36. Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3.
Geum D; Sun W; Paik SK; Lee CC; Kim K
Mol Reprod Dev; 1997 Apr; 46(4):450-8. PubMed ID: 9094091
[TBL] [Abstract][Full Text] [Related]
37. Surrogate endpoint biomarkers for phase II cancer chemoprevention trials.
Kelloff GJ; Boone CW; Crowell JA; Steele VE; Lubet R; Doody LA
J Cell Biochem Suppl; 1994; 19():1-9. PubMed ID: 7823579
[TBL] [Abstract][Full Text] [Related]
38. The molecular basis for cellular transformation: implications for esophageal carcinogenesis.
Rosen N
Semin Oncol; 1994 Aug; 21(4):416-24. PubMed ID: 8042039
[No Abstract] [Full Text] [Related]
39. Growth factors, oncogenes, and multistage carcinogenesis.
Weinstein IB
J Cell Biochem; 1987 Mar; 33(3):213-24. PubMed ID: 3553218
[TBL] [Abstract][Full Text] [Related]
40. Oncogenes and oncoproteins as tumor markers.
Pillai R
Eur J Surg Oncol; 1992 Oct; 18(5):417-24. PubMed ID: 1426290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
